GlassScriptPhysician profile
Casey R Steen
NPI 1811381775
$1,728.77
in general payments reported to CMS, 2019-2025
17 companies · $89.64 in 2025
The $89.64 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $226 · 2021: $248 · 2022: $196 · 2023: $538 · 2024: $213 · 2025: $89.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $713.20 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $319.90 | 2019-2024 | Xarelto |
| Vifor Pharma, INC. | $129.84 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $127.62 | 2022-2024 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.75 | 2023-2025 | Xifaxan |
| Inari Medical, INC. | $44.26 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $38.13 | 2023-2024 | |
| Gilead Sciences, INC. | $31.77 | 2023 | Veklury |
| Dendreon Pharmaceuticals LLC | $30.32 | 2019 | |
| Abbvie INC. | $29.74 | 2022-2023 | Avycaz |
| Ceribell, INC. | $29.53 | 2025 | Pocket Eeg Device |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.00 | 2019 | |
| Amgen INC. | $23.99 | 2023 | Repatha |
| Abbott Laboratories | $17.55 | 2024 | Jot Dx |
| Baxter Healthcare | $16.58 | 2023 | Hillrom - Life 2000 Ventilation System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.54 | 2023 | Watchman Flx |
| Allergan, INC. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Steen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.